Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/75899
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGordon, C.-
dc.contributor.authorThompson, C.-
dc.contributor.authorCarapetis, J.-
dc.contributor.authorTurnidge, J.-
dc.contributor.authorKilburn, C.-
dc.contributor.authorCurrie, B.-
dc.date.issued2012-
dc.identifier.citationThe Pediatric Infectious Disease Journal, 2012; 31(12):1269-1271-
dc.identifier.issn0891-3668-
dc.identifier.issn1532-0987-
dc.identifier.urihttp://hdl.handle.net/2440/75899-
dc.description.abstractDespite the need for effective vancomycin therapy, there are few data guiding vancomycin monitoring in children. We reviewed retrospectively vancomycin use in children 1 month to 12 years of age. Initial and adjusted target trough vancomycin concentrations in serum were infrequently achieved regardless of the dosing schedule. Currently recommended trough concentrations need to be re-examined with a more detailed pharmacokinetic study in children.-
dc.description.statementofresponsibilityClaire L. Gordon, Chantelle Thompson, Jonathan R. Carapetis, John Turnidge, Charles Kilburn and Bart J. Currie-
dc.language.isoen-
dc.publisherLippincott Williams & Wilkins-
dc.rightsCopyright: © 2012 Lippincott Williams & Wilkins, Inc.-
dc.source.urihttp://dx.doi.org/10.1097/inf.0b013e31826a3eaf-
dc.subjectvancomycin-
dc.subjectStaphylococcus aureus-
dc.subjecttherapeutic drug monitoring-
dc.titleTrough concentrations of vancomycin: adult therapeutic targets are not appropriate for children-
dc.typeJournal article-
dc.identifier.doi10.1097/INF.0b013e31826a3eaf-
pubs.publication-statusPublished-
dc.identifier.orcidTurnidge, J. [0000-0003-4240-5578]-
Appears in Collections:Aurora harvest
Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.